Event Type
Disclosure
Mandatory
Variant
8-K
of Current Report on Form 8-K. Item 3.03 Material Modification to Rights of Security Holders. The information set forth in Items 5.03 and 8.01 of this report is
to the extent such information is responsive to the disclosure requirements of Item 3.03 of Current Report on Form 8-K. Item 5.03 Amendments to Articles of Inco
Other Events. On January 27, 2026, we completed the initial closing of our Regulation A offering of up to 4,854,000 units (each, an “Investor Unit” and collecti
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 1.1 Selling Agency Agreement, dated January 5, 2026, between Daré Bioscience, Inc. and